Orion completes acquisition of LegoChem Biosciences

Reporter Kim SangJin / approved : 2024-04-01 03:57:19
  • -
  • +
  • 인쇄

(Photo = Yonhap news)

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Orion said it has become the largest shareholder after paying 548.5 billion won in stock prices to acquire a 25.73% stake in LegoChem Biosciences.

Orion participated in LegoChem Biosciences's third-party paid-in capital increase and was allocated 7,963,283 shares for 59,000 won. It purchased 1.4 million old shares at a base price of 56,186 won from its founder Kim Yong-joo and CEO Park Se-jin to secure a total of 9,363,283 shares.

It plans to develop new drugs through its affiliate LegoChem Biosciences and complete its business portfolio for the group's sustainable growth.

 

 

Alphabiz Reporter Kim SangJin(hoondork1977@alphabiz.co.kr)

어플

주요기사

Kolmar Korea Certified as Year’s First ‘Reshoring’ Company; To Invest 100 Billion KRW in Smart Factory Expansion2026.02.06
Court Dismisses Additional Lawsuits by Shareholders Over "Invossa" Controversy, Ruling in Favor of Kolon2026.02.06
Nvidia Delays China H200 Chip Exports Amid Ongoing Talks With U.S. Government2026.02.06
Naver Issues Formal Apology Over Exposure of Celebrities’ and Politicians’ Past "Ji-sik-iN" Posts2026.02.06
CJ Logistics Designated as Unfaithful Disclosure Corporation Over Delayed Notice of $2.7B Libyan Counterclaim2026.02.06
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사